|
ZNF569 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.558800E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.468500E-02 |
| Normal-vs-Stage2 |
5.228600E-01 |
| Normal-vs-Stage3 |
2.02409999999764E-05 |
| Normal-vs-Stage4 |
1.76033999998992E-05 |
| Stage1-vs-Stage2 |
9.044200E-01 |
| Stage1-vs-Stage3 |
4.441400E-03 |
| Stage1-vs-Stage4 |
6.961300E-03 |
| Stage2-vs-Stage3 |
1.375410E-01 |
| Stage2-vs-Stage4 |
1.224370E-01 |
| Stage3-vs-Stage4 |
9.169200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.978700E-04 |
| Normal-vs-AfricanAmerican |
8.25500000000146E-05 |
| Normal-vs-Asian |
4.432600E-01 |
| Caucasian-vs-AfricanAmerican |
5.583800E-02 |
| Caucasian-vs-Asian |
9.783800E-01 |
| AfricanAmerican-vs-Asian |
4.810000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.986300E-04 |
| Normal-vs-Female |
6.201300E-03 |
| Male-vs-Female |
6.224800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.489740E-02 |
| Normal-vs-Age(41-60Yrs) |
3.696000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.370690E-04 |
| Normal-vs-Age(81-100Yrs) |
2.723300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.243200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.201800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.740400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.360000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.089030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.327580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.793800E-01 |
| Normal-vs-Grade 2 |
6.435600E-01 |
| Normal-vs-Grade 3 |
2.37760000021403E-07 |
| Normal-vs-Grade 4 |
2.53119969428894E-10 |
| Grade 1-vs-Grade 2 |
5.867200E-01 |
| Grade 1-vs-Grade 3 |
2.597900E-02 |
| Grade 1-vs-Grade 4 |
7.622700E-04 |
| Grade 2-vs-Grade 3 |
2.790900E-04 |
| Grade 2-vs-Grade 4 |
4.95459999694248E-08 |
| Grade 3-vs-Grade 4 |
2.220900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.012600E-01 |
| Normal-vs-ccB subtype |
4.84609999906738E-08 |
| ccA subtype-vs-ccB subtype |
6.46739999998758E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.282800E-03 |
| Normal-vs-N1 |
1.324370E-03 |
| N0-vs-N1 |
3.386100E-02 |
|
|
